Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience | Zendy

Jessica Simon | Zendy; David Sandler | Zendy; J. H. Warwick Pexman | Zendy; Michael D. Hill | Zendy; Alastair M. Buchan | Zendy

Open Access

Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience

Author(s) -

Jessica Simon,

David Sandler,

J. H. Warwick Pexman,

Michael D. Hill,

Alastair M. Buchan

Publication year - 2004

Publication title -

age and ageing

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.014

H-Index - 143

eISSN - 1468-2834

pISSN - 0002-0729

DOI - 10.1093/ageing/afh031

Subject(s) - medicine , recombinant tissue plasminogen activator , stroke (engine) , tissue plasminogen activator , mortality rate , t plasminogen activator , fibrinolytic agent , surgery , thrombolysis , ischemic stroke , ischemia , myocardial infarction , mechanical engineering , modified rankin scale , engineering

Acute ischaemic stroke is common in older people. There is one licensed acute treatment, intravenous recombinant tissue plasminogen activator, but little information is available on its safety in over 80 year olds.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research